GOP Senators In Tight Races Mostly Mum On Drug-Pricing Bill

By Rachel Cohrs / August 23, 2019 at 3:32 PM

Several Republican senators in tough re-election races haven’t been playing up the upper chamber’s accomplishments on drug-pricing over lawmakers’ August recess, analysts say, though the most impactful bill would save taxpayers more than $100 billion.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.